Return to our Home Page


Products
Product Spotlights
Calbiochem Product Spotlights
Biochemical Product Spotlights
K-LISA™ mTOR Activity Kit
 
mTOR (mammalian Target of Rapamycin) was originally identified in Saccharomyces cerevisiae where mutations of the protein kinase, TOR, confer rapamycin resistance. mTOR is a large (>250 kDa) class IV PI-3 kinase family member with protein kinase activity, but lacks any lipid kinase activity. mTOR forms a complex with the 12 kDa cytosolic protein, FKBP-12 and rapamycin that functions to arrest the cell cycle in the G1 phase. Cell cycle arrest by the mTOR complex requires the presence of the intact kinase domain of mTOR and, in particular, a conserved serine within this domain, Ser2448, which has been identified as an Akt/PKB-mediated phosphorylation site. Biomarkers indicate that the mTOR pathway is hyperactive in certain types of cancers, suggesting that mTOR could be an attractive target for cancer therapy. Activated mTOR may provide tumor cells with a growth advantage by promoting protein synthesis, which is the best-described physiological function of mTOR signaling. mTOR regulates Akt activity, a crucial downstream effector in the PI-3K–PTEN pathway, which controls cell proliferation and survival. Targeting this function of mTOR may also have therapeutic potential.

The K-LISA™ mTOR Activity Kit (Cat. No. CBA055) is suitable for measuring the kinase activity of purified or partially purified preparations of mTOR or mTOR that have been immunoprecipitated from crude cell lysates. This assay is also useful for in vitro mTOR inhibitor screening and for assessing the regulation of mTOR in cell signaling.
 
 
The K-LISA™ mTOR Activity Kit is:
Versatile: can detect kinase activity or be used for inhibitor screening
Useful: mTOR Standard, Substrate, and Inhibitors are provided
Convenient: 96-well ELISA-based format, non-radioactive detection
Detection: Colorimetric, using HRP-Antibody Conjugate and TMB Substrate
 
Activity of mTOR Standard 
 
Rapamycin + FKBP12 Inhibition of mTOR Kinase Activity Figure 2. Rapamycin + FKBP12 Inhibition of mTOR Kinase Activity

FKBP12 + Rapamycin inhibition of mTOR Standard. The activity of the mTOR Standard, (50 ml) was determined as in Figure 1 in the presence of either Rapamycin (20 mM; Cat. No. 553210 or 553211), Rapamycin (20 mM) + GST-FKBP12 (37 mg/ml), or Wortmannin (10 mM; Cat. No. 681675; also included with the kit)
 
Related Products
 
Antibodies
 
Assay Kits
 
Inhibitors
 
Proteins